Related Experiment Videos
Free radicals and myocardial injury: pharmacologic implications
Circulation
|July 1, 1986
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Allometry of sexual size dimorphism in dioecious plants: do plants obey Rensch's rule?
The American naturalist·2011
Thrombostatin FM compounds: direct thrombin inhibitors - mechanism of action in vitro and in vivo.
Journal of thrombosis and haemostasis : JTH·2008
Thrombostatin inhibits cyclic flow variations in stenosed canine coronary arteries.
Thrombosis and haemostasis·2002
Conversion of atrial fibrillation by the experimental antiarrhythmic drug tedisamil in two canine models.
Journal of cardiovascular electrophysiology·2001
Implications of increased left ventricular mass index on in-hospital outcomes in patients undergoing aortic valve surgery.
The Journal of thoracic and cardiovascular surgery·2001
METTL7B Mitigates Hypertension and Vascular Remodeling.
Circulation·2026
The Timing and Characteristics of Supplemental Indications for Medicines.
The American journal of managed care·2026
Therapeutic effect of Fuzheng Yixin decoction on cardiac insufficiencythe soluble guanylyl cyclase-cyclic guanosine monophosphate-protein kinase G pathway in a doxorubicin-induced dilated cardiomyopathy rat model.
Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan·2026
Shaofu Zhuyu decoction can inhibit the progression of endometriosis fibrosis through the transforming growth factor-β1/ smads signaling pathway mediated by 5' adenosine monophosphate-activated protein kinase.
Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan·2026
Baihe Dihuang decoction activates cannabinoid type 2 receptor to regulate microglial polarization and alleviate anxiety-like behavior in chronic restraint stress mice.
Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan·2026
Real-World Treatment Patterns and Clinical Outcomes with Cyclosporine 0.1% in Semifluorinated Alkane for Dry Eye Disease.
Clinical ophthalmology (Auckland, N.Z.)·2026